| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
AORT
Artivion
|
May 08, 2026 | BUY |
Strong Buy
+91.6% avg upside
8 analysts
|
$48.00
126.60% Upside
|
-20.0% |
|
LMAT
Lemaitre Vascular
|
May 06, 2026 | BUY |
Strong Buy
+8.3% avg upside
15 analysts
|
$127.00
35.27% Upside
|
-16.5% |
|
ATRC
Atricure
|
Feb 18, 2026 | BUY |
Strong Buy
+59.3% avg upside
12 analysts
|
$52.00
80.47% Upside
|
-12.8% |
|
STXS
Stereotaxis
|
Dec 16, 2025 | BUY |
Strong Buy
+127.1% avg upside
7 analysts
|
$4.00
112.84% Upside
|
-25.2% |
|
STIM
Neuronetics
|
Mar 05, 2025 | BUY |
Strong Buy
+387.8% avg upside
6 analysts
|
$7.00
469.15% Upside
|
-74.0% |
|
AVNS
Avanos Medical
|
Feb 28, 2025 | HOLD |
Buy
+9.6% avg upside
5 analysts
|
— | -6.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.